TrialJAMA internal medicine2025

Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial.

Thorsten Lehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.